Search clinical trials for: CP-4055

Total 2024 results

Clavis Pharma

Completed

Clinical Study of Previously Untreated Patients With Malignant Melanoma

Neoplasm Metastasis | Malignant Melanoma

United States, Norway, Sweden
Clavis Pharma

Completed

A Phase II Study of CP-4055 as Second Line Therapy in Patients With Advanced Colorectal Cancer

Colorectal Cancer | Advanced Colorectal Cancer

United Kingdom
Clavis Pharma
Syneos Health; Theradex; CardiaBase; Learn & Confirm

Completed

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Relapsed/Refractory AML

United Kingdom, Spain
Clavis Pharma
Syneos Health; Theradex

Completed

A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia

Acute Myeloid Leukemia

United States, Norway, Germany, France
Clavis Pharma

Completed

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Malignant Melanoma

United States, Sweden, Norway
Clavis Pharma

Completed

A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies

AML | Hematologic Malignancies

United States, United Kingdom, France, Germany, Italy, Norway
Clavis Pharma

Completed

A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer

Ovarian Cancer

Belgium, Italy
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Completed

The Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CML

CML, CML-CP,MMR,TKI

China
Tehran University of Medical Sciences
Hormozgan University of Medical Sciences

Unknown

Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy

Cerebral Palsy, Spastic

Iran, Islamic Republic of
Academisch Medisch Centrum - Universiteit van Amsterdam...
Erasmus Medical Center

Terminated

Sorafenib PK in Patients With Advanced HCC and Child-Pugh B (SORBE)

BCLC Stage C HCC | CP-B Liver Cirrhosis

Netherlands
Tanta University

Completed

MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates

Neonatal Hyperbilirubinemia

Egypt
University of Calgary

Recruiting

Evaluating the Impacts of a Single Session of Robot Assisted Gait Training With a Trexo

Physical Disability | Developmental Disability | CP (Cerebral Palsy)

Canada
Cairo University

Active, not recruiting

Core Stabalization and Rebound Therapy and CP

Balance | Whole Body Vibration | Rebound Therapy | cp

Egypt
HEIDEGGER CP

Recruiting

Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial) (NutriPhyT)

Critical Illness | Malnutrition | ICU Acquired Weakness

Switzerland
Cairo University

Recruiting

Influence of Surface Characteristics of Gait Training on Gait Kinematics and Walking Capacity in Children With Diplegic CP

Diplegic Cerebral Palsy

Egypt
Cairo University

Recruiting

Plyometric Training Versus Strengthening Exercise On Children With Hemiplegia

Children With Hemiplegic cp | Effect of Plyometic Exercises

Egypt
Shenzhen Second People's Hospital

Recruiting

Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP

Chronic Myeloid Leukemia | Dasatinib | BCR-ABL

China
Becton, Dickinson and Company

Completed

Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans (ARCTR05)

Contrast Enhanced Computed Tomography

United States
Shenzhen Second People's Hospital

Recruiting

Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.

Chronic Myeloid Leukemia, Chronic Phase | Olverembatinib | Tyrosine Kinase Inhibitors

China
East Carolina University

Completed

Virtual Third-Wave Intervention for Internalized Weight Bias Combined With a Weight Loss Program

Weight Loss | Weight Prejudice

United States
University Hospital, Basel, Switzerland

Recruiting

Swiss Itch Registry (SWITCHR)

Chronic Pruritus (CP)

Switzerland
Nabriva Therapeutics AG

Recruiting

PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age) (Pediatric_PK)

Pediatric ALL

United States
Post Graduate Institute of Medical Education and...

Completed

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis

Chronic Pulmonary Aspergillosis

India
Brigham and Women's Hospital

Recruiting

CP101 for the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States
Lille Catholic University
Région Nord-Pas de Calais, France; Made for Movement; Initiatives de parents... and other collaborators

Completed

Tolerance of a Motorized Orthosis Reproducing Walking Movement vs Conventional Standing-up Devices in Child With CP (EOMEC/CP)

CP (Cerebral Palsy)

France
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Unknown

Effectiveness of a Psychoeducation and Support Protocol by Phone in the Aid of Caregivers of Patients With Dementia.

Dementia

Brazil
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE (HOPES)

Adverse Events | Progress-free Survival | Overall Response Rate
Pfizer

Terminated

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Obesity

United States, Australia, Canada, Brazil, Slovakia, Czech Republic, Argentina, Germany, Mexico, United Kingdom, Sweden
University Hospital, Brest

Completed

Functional Effects and Impact on Motor Neuronal Activity of Early and Intensive Motrice (Hand and Arm Bimanual Intensive Therapy Including Lower Extremities: HABIT-ILE) Reeducation in Children With Pre-school Bilateral Cerebral Palsy (MOOV)

Cerebral Palsy

France
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma

Diffuse Large B Cell Lymphoma

China
Shanghai CP Guojian Pharmaceutical Co., Ltd.

Completed

Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer

Metastatic Breast Cancer

China
Il-Yang Pharm. Co., Ltd.

Completed

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Hematologic Diseases | Leukemia | Leukemia, Myeloid | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Philadelphia Chromosome

India, Korea, Republic of, Thailand
Siemens Molecular Imaging

Terminated

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

Breast Cancer

United States
Pfizer

Terminated

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

Obesity

Australia, United States, Korea, Republic of, Spain, France, United Kingdom, Germany, Sweden, Argentina, Chile, Mexico
University of California, San Francisco
California Breast Cancer Research Program

Completed

Telephone-Based Decision Support for Rural Patients

Breast Cancer

United States
Institute for Clinical and Experimental Medicine

Recruiting

Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP (UNLOAD-AMI)

Myocardial Infarction | Shock, Cardiogenic | Remodeling, Ventricular

Czechia
Riphah International University

Recruiting

Oral Motor Facilitation Technique And Traditional Exercises on Children With Cerebral Palsy

Cerebral Palsy (CP)

Pakistan
Assaf-Harofeh Medical Center

Unknown

Go For It: to Improve Levels of Daily Physical Activity and to Reduce the Sedentary Life Style of Adolescents With CP

Cerebral Palsy (CP)
Acorda Therapeutics

Completed

Safety and Tolerability of Dalfampridine in Subjects With Cerebral Palsy

Cerebral Palsy (CP)

United States
Pfizer

Completed

ACTiF- Assessment of Closed Tibial Fractures

Tibial Fractures

United States, Australia, Canada, Spain, Turkey, Croatia, India, Bosnia and Herzegovina, Japan, Russian Federation, South Africa
Pfizer

Completed

Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan

Rheumatoid Arthritis

Japan
HEIDEGGER CP
Aalborg University

Recruiting

GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU)

Hyperglycemia | Hypoglycemia | Critical Illness | Protein Deficiency | Energy Supply; Deficiency, Severe

Switzerland
Shenzhen Second People's Hospital
Hainan General Hospital; Sanya Central Hospital; First Affiliated Hospital of... and other collaborators

Recruiting

Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Chronic Myeloid Leukemia, Chronic Phase | Flumatinib | Imatinib

China
Tatyasaheb Kore Dental College

Completed

"Effect of Scaling and Root Planing on Liver Function Test (Alanine Aminotransferase and Aspartate Aminotransferase) in Systemically Healthy - Chronic Periodontitis Subjects: a Clinical Trial."

Chronic Periodontitis (CP) Subjects.
Pfizer

Completed

A Study Of CP-690,550 In Stable Kidney Transplant Patients

Kidney Transplant

United States
Inova Health Care Services

Completed

Characteristics of COVID-19 Infection Among PREGnant Women (CCOVID-PREG)

Pregnancy Related | Corona Virus Infection

United States
Joanne Kurtzberg, MD
The Marcus Foundation

Completed

A Study of UCB and MSCs in Children With CP: ACCeNT-CP (ACCeNT-CP)

Cerebral Palsy

United States
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

Psoriasis

Japan
Anthera Pharmaceuticals

Terminated

Phase III ALTU-135 CP Safety Trial (DIGEST CP)

Exocrine Pancreatic Insufficiency

United States
Riphah International University

Completed

Effect of PNF on Selective Motor Control and Balance in CP

CP (Cerebral Palsy)

Pakistan

Search clinical trials for: CP-4055

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations